TABLE 2

Serum biochemistry at sacrifice, after 4 weeks of phosphate binder treatment

	N	Weight	Creatinine	Ca	P	iPTH	Ht	Ferritin
		g	µM	mM		pg/ml	%	ng/ml
Non-CRF control	8	410 ± 7	44.6 ± 2.1	2.40 ± 0.03	2.15 ± 0.11	105 ± 14	45.8 ± 1.0	176 ± 28
Non-CRF PA21 5%	8	384 ± 16	42.8 ± 3.6	2.43 ± 0.05	1.70 ± 0.12	134 ± 50	46.7 ± 1.3	291 ± 121
Non-CRF CaCO₃ 3%	8	362 ± 15	46.7 ± 3.9	2.50 ± 0.35	2.14 ± 0.22	102 ± 9	44.5 ± 2.5	324 ± 78
CRF control	19	255 ± 7^{^a}	188 ± 14^{^a}	2.38 ± 0.12	2.91 ± 0.24	3261 ± 397	27.4 ± 1.4^{^a}	381 ± 51
CRF PA21 5%	20	256 ± 8^{^a}	180 ± 15^{^a}	2.41 ± 0.03	2.21 ± 0.09^{^b}	1138 ± 228^{^b}	26.7 ± 1.0^{^a}	585 ± 76
CRF PA21 1.5%	9	266 ± 9^{^a}	169 ± 16^{^a}	2.23 ± 0.04	2.29 ± 0.25^{^c}	2727 ± 695^{^d}	27.3 ± 2.2^{^a}	632 ± 104
CRF PA21 0.5%	9	250 ± 9^{^a}	188 ± 18^{^a}	2.39 ± 0.07	2.74 ± 0.37	4830 ± 624^{^d}	32.9 ± 1.8^{^a}	500 ± 131
CRF CaCO₃ 3%	19	245 ± 8^{^a}	191 ± 15^{^a}	2.39 ± 0.06	2.06 ± 0.11^{^b}	1299 ± 300^{^b}	28.7 ± 1.8^{^a}	691 ± 115^{^b}